David Ettinger, MD
Enriched profileAlex Grass professor of Oncology · Johns Hopkins School of Medicine
David Ettinger is Alex Grass professor of Oncology at Johns Hopkins School of Medicine. ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 13 Nov 2026
Overview
Updated 16 Nov 2026
David Ettinger, M.D., is Alex Grass professor of Oncology at Johns Hopkins School of Medicine. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 2 companies, 6 NIH-funded awards (1985–1997).
- Top research focus: Lung Cancer (NSCLC/SCLC)
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 16 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Nov 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC.
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
Sponsor: Eastern Cooperative Oncology Group
Industry payments
Updated 13 Nov 2026
2 companies reported payments to CMS in program years 2022–2023. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20232 payments
- PFIZER INC.Program year20221 payment
NIH funding
Updated 13 Nov 2026
6 NIH research awards on record, funded 1985–1997 per NIH RePORTER. The latest:
- 9-AMINO-(20(S))-CAMPTOTECIN (9AC) IN ADVANCED NON-SMALL CELL LUNG CANCER
Johns Hopkins University
FY1997M01RR000052
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Background & recognition
Updated 13 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
FACP, FCCP
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →d17k4s9qki18rb.cloudfront.net ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancernetwork.com ↗
- Co-Chair
Lung Cancer Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sciencedirect.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Myron Weisfeldt, MD
Johns Hopkins School of Medicine
Arthur Burnett, MD
Johns Hopkins School of Medicine
Richard Jones, MD
Johns Hopkins School of Medicine
Matthias Holdhoff, MD
Johns Hopkins School of Medicine
Marc Ladanyi, MD
Memorial Sloan Kettering Cancer Center
Ignacio Wistuba, MD
Moffitt Cancer Center
Pasi Janne, MD, PhD
Dana-Farber Cancer Institute
John Minna, MD
University of Texas Southwestern Medical Center